Cleared Traditional

K033187 - INTERLAB IMMUNOFIXATION TEST(S)

K033187 is the FDA 510(k) clearance for INTERLAB IMMUNOFIXATION TEST(S) by Interlab S.R.L.. It is a Class 2 Immunology device (product code CFF) cleared through the Traditional 510(k) pathway after a 49-day FDA review.

K033187 · Interlab S.R.L. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2003
Decision
49d
Days
Class 2
Risk

K033187 is an FDA 510(k) clearance for the INTERLAB IMMUNOFIXATION TEST(S). Classified as Immunoelectrophoretic, Immunoglobulins, (g, A, M) (product code CFF), Class II - Special Controls.

Submitted by Interlab S.R.L. (East Stroudsburg, US). The FDA issued a Cleared decision on November 19, 2003 after a review of 49 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5510 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Interlab S.R.L. devices

Submission Details

510(k) Number K033187 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 01, 2003
Decision Date November 19, 2003
Days to Decision 49 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
55d faster than avg
Panel avg: 104d · This submission: 49d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CFF Immunoelectrophoretic, Immunoglobulins, (g, A, M)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - CFF Immunoelectrophoretic, Immunoglobulins, (g, A, M)

All 17
Devices cleared under the same product code (CFF) and FDA review panel - the closest regulatory comparables to K033187.
HYDRASHIFT 2/4 daratumumab
K190851 · Sebia · May 2019
HYDRASHIFT 2/4 daratumumab, daratumumab Control
K172195 · Sebia · Jan 2018
SPIFE IFE-15 PENTAVALENT, MODEL 3456, SPIFE IFE-9 PENTAVALENT KIT, MODEL 3457, SPIFT IFE-6 PENTAVALENT KIT, MODEL 3458
K061069 · Helena Laboratories · Jul 2006
SPIFE 3000 TITAN GEL IGG IEF KIT, MODEL 3389
K024162 · Helena Laboratories · Feb 2003
PARAGON CZE 2000 CAPILLARY ELECTROPHORESIS SYSTEM AND BUFFER-100
K002799 · Beckman Coulter, Inc. · Oct 2000
K-ASSAY IGM
K993323 · Kamiya Biomedical Co. · Nov 1999